Cargando…

COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right

Detalles Bibliográficos
Autores principales:	Garg, Rakesh, Chakraborty, Raunaq
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438834/ https://www.ncbi.nlm.nih.gov/pubmed/36060179 http://dx.doi.org/10.4103/joacp.JOACP_423_20

Ejemplares similares

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers
por: Dixit, Prashant Kumar, et al.
Publicado: (2021)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)

Hydroxychloroquine in the prophylaxis of COVID 19: A survey of safety on the healthcare workers in India
por: Mukhopadhyay, Sandip, et al.
Publicado: (2021)

Risks of hydroxychloroquine use for COVID-19 prophylaxis
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
por: Grant-Kels, Jane M.
Publicado: (2020)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
por: Faruqui, Atiya R., et al.
Publicado: (2021)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?
por: Mir, Tajamul H.
Publicado: (2021)

Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
por: Shankar, Pathiyil Ravi, et al.
Publicado: (2021)

The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
por: Dauby, Nicolas, et al.
Publicado: (2021)

DRUG PROPHYLAXIS OF SCHIZOPHRENIA ?
por: Nischal, Anil
Publicado: (1997)

Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic
por: Gagneux-Brunon, Amandine, et al.
Publicado: (2021)

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis
por: Kessler, Chiara, et al.
Publicado: (2020)

Rabies Prophylaxis for Pregnant Women
por: Abazeed, Mohamed E., et al.
Publicado: (2007)

HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)

Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
por: Rojas-Serrano, Jorge, et al.
Publicado: (2022)

Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of “goals of care”
por: Tleyjeh, Prof. Imad M., et al.
Publicado: (2021)

Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
por: Singh, Harmanjit, et al.
Publicado: (2021)

Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed()
por: Tahiri Joutei Hassani, Rachid, et al.
Publicado: (2020)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Obesity, pregnancy, and prophylaxis for venous thromboembolism
por: Nawaz, Iqra, et al.
Publicado: (2023)

Is it time to move to systematic antithrombotic prophylaxis or therapy for all patients with COVID-19 disease?
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2021)

Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients
por: Brito-Azevedo, Anderson
Publicado: (2020)

To zinc or not to zinc for COVID-19 prophylaxis or treatment?
por: Chiang, Kate Chander, et al.
Publicado: (2021)

Reply to “The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of ‘goals of care’”
por: Dauby, Nicolas, et al.
Publicado: (2021)

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
por: Tilangi, Praveen, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

Methods of Prophylaxis and Therapy for Emporiatrics: New or Ancient
por: Siahpoosh, MB, et al.
Publicado: (2012)

Risk factors and antibiotic prophylaxis of cellulitis in cirrhosis
por: Basyigit, Sebahat
Publicado: (2015)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l80me58raa06a9stubcuph543s